Cleared Dual Track

K260333 - LIAISON NES Group A Strep

Also marketed or referenced as:
LIAISON NES Group A Strep Control Swab Kit

K260333 is an FDA 510(k) clearance for LIAISON NES Group A Strep, manufactured by Diasorin Molecular, LLC. The device is a Class 2 Microbiology device with product code PGX cleared through the Dual Track 510(k) pathway after a 133-day FDA review.

K260333 · Diasorin Molecular, LLC · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2026
Decision
133d
Days
Class 2
Risk

K260333 is an FDA 510(k) clearance for the LIAISON NES Group A Strep. Classified as Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System (product code PGX), Class II - Special Controls.

Submitted by Diasorin Molecular, LLC (Cypress, US). The FDA issued a Cleared decision on June 15, 2026 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.2680 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Diasorin Molecular, LLC devices

FDA 510(k) Submission Details - K260333

510(k) Number K260333 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 2026
Decision Date June 15, 2026
Days to Decision 133 days
Submission Type Dual Track
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
31d slower than avg
Panel avg: 102d · This submission: 133d
Pathway characteristics

PGX Device Classification - Class 2, Special Controls

Product Code PGX Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.2680
Definition An In Vitro Diagnostic Test For The Detection Of Group A, C And G Beta Hemolytic Streptococcus In Throat Swab Specimens From Symptomatic Patients.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - PGX Groups A, C And G Beta-hemolytic Streptococcus Nucleic Acid Amplification System

All 9
Devices cleared under the same product code (PGX) and FDA review panel - the closest regulatory comparables to K260333.
Accula Strep A Test
K201269 · Mesa Biotech, Inc. · Nov 2020
GenePOC Strep A
K183366 · Genepoc, Inc. · Mar 2019
Alere i Strep A 2, Alere i instrument, Alere i Strep A 2 Control Swab Kit
K173653 · Alere Scarborough, Inc. · May 2018
Xpert Xpress Strep A
K173398 · Cepheid · Apr 2018
Xpert Xpress Strep A
K172126 · Cepheid · Sep 2017
Solana Strep Complete Assay
K162274 · Quidel Corporation · Oct 2016